Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Block vs Trigger Point Injection for Abdominal Wall Pain
NCT01906944Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2012
- Primary completion
- Aug 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine, triamcinolone in abdominal pain, sponsored by Mayo Clinic. Started Jan 2012; status: completed.
02
Drugs
bupivacainetriamcinolone
03
Conditions
abdominal pain
Beyond the preview
Go deeper on NCT01906944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01906944.